Only retatrutide adds glucagon for the full trifecta
Patient-centric considerations are equally important, with a growing demand for treatments that are easier to use , whether that means less frequent dosing, oral options, or alternatives to injections
Camilleri M, Lupianez-Merly C
Image Credit: Maria Dryfhout/Shutterstock.com A single enzyme shown to be a primary predictor of COVID-19 severity Scientists from the University of Arizona, Stony Brook University, and Wake Forest University School of Medicine have reported findings that the enzyme phospholipase A2 group IIA, referred to as sPLA2-IIA, may be the most important factor in predicting which patients with severe COVID-19 eventually succumb to the virus
however, large meals or rapid eating can trigger nausea or gastroparesis-like symptoms in some patients
All claims must be true, not misleading, and include information regarding risks and negative effects